Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EBITDA (2016 - 2025)

Stemtech's EBITDA history spans 6 years, with the latest figure at -$127115.0 for Q3 2025.

  • On a quarterly basis, EBITDA rose 94.37% to -$127115.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$145406.0, a 97.74% increase, with the full-year FY2024 number at -$4.1 million, up 17.74% from a year prior.
  • EBITDA hit -$127115.0 in Q3 2025 for Stemtech, down from $389146.0 in the prior quarter.
  • Over the last five years, EBITDA for STEK hit a ceiling of $17.0 million in Q3 2022 and a floor of -$24.6 million in Q2 2022.
  • Historically, EBITDA has averaged -$1.4 million across 5 years, with a median of -$639252.0 in 2024.
  • The widest YoY moves for EBITDA: up 393.92% in 2022, down 8215.81% in 2022.
  • Tracing STEK's EBITDA over 5 years: stood at -$584502.0 in 2021, then soared by 84.14% to -$92699.0 in 2022, then crashed by 1208.61% to -$1.2 million in 2023, then skyrocketed by 130.16% to $365863.0 in 2024, then plummeted by 134.74% to -$127115.0 in 2025.
  • Business Quant data shows EBITDA for STEK at -$127115.0 in Q3 2025, $389146.0 in Q2 2025, and -$773300.0 in Q1 2025.